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We describe genomic structures of 59 X-chromosome segmental duplications that include the proteolipid protein
1 gene (PLP1) in patients with Pelizaeus-Merzbacher disease. We provide the ﬁrst report of 13 junction sequences,
which gives insight into underlying mechanisms. Although proximal breakpoints were highly variable, distal break-
points tended to cluster around low-copy repeats (LCRs) (50% of distal breakpoints), and each duplication event
appeared to be unique (100 kb to 4.6 Mb in size). Sequence analysis of the junctions revealed no large homologous
regions between proximal and distal breakpoints. Most junctions had microhomology of 1–6 bases, and one had
a 2-base insertion. Boundaries between single-copy and duplicated DNA were identical to the reference genomic
sequence in all patients investigated. Taken together, these data suggest that the tandem duplications are formed
by a coupled homologous and nonhomologous recombination mechanism. We suggest repair of a double-stranded
break (DSB) by one-sided homologous strand invasion of a sister chromatid, followed by DNA synthesis and
nonhomologous end joining with the other end of the break. This is in contrast to other genomic disorders that
have recurrent rearrangements formed by nonallelic homologous recombination between LCRs. Interspersed re-
petitive elements (Alu elements, long interspersed nuclear elements, and long terminal repeats) were found at 18
of the 26 breakpoint sequences studied. No speciﬁc motif that may predispose to DSBs was revealed, but single
or alternating tracts of purines and pyrimidines that may cause secondary structures were common. Analysis of
the 2-Mb region susceptible to duplications identiﬁed proximal-speciﬁc repeats and distal LCRs in addition to the
previously reported ones, suggesting that the unique genomic architecture may have a role in nonrecurrent re-
arrangements by promoting instability.
Introduction
Pelizaeus-Merzbacher disease (PMD [MIM 312080]) is
caused predominantly by submicroscopic duplications
of chromosome Xq22.2 that include the entire proteo-
lipid protein 1 gene (PLP1). PLP1 is a dosage-sensitive
gene, and either gain or loss of copy number can result
in neurological disorders in both humans and animals
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(Raskind et al. 1991; Ellis and Malcolm 1994; Kagawa
et al. 1994; Readhead et al. 1994). PMD is characterized
by dysmyelination and demyelination within the CNS,
and the clinical phenotype is variable—with signs in-
cluding nystagmus, psychomotor developmental delay,
ataxia, and spasticity—and onset is within the ﬁrst year
of life (Boulloche and Aicardi 1986; Hodes et al. 1993).
Variation in both duplication size and position of
proximal and distal breakpoints has been shown by our
work and that of others (Woodward et al. 1998, 2000;
Inoue et al. 1999). Rearrangements are typically tandem
head-to-tail duplications within Xq22.2, and a mech-
anism of unequal sister-chromatid exchange during
spermatogenesis has been proposed (Woodward et al.
1998; Inoue et al. 1999; Mimault et al. 1999). Several
atypical cases of apparent transposition events have also
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been described in which an additional copy of the PLP1
gene has integrated at noncontiguous sites on the X
chromosome (Xp22 and Xq26) (Hodes et al. 2000;
Woodward et al. 2003). The mechanism by which these
atypical nontandem duplication events in PMD arise is
currently unknown. We have also described triplication
and quintuplication events that involve PLP1 (Wolf et
al. 2005). The mechanism by which these are generated
is also not known.
DNA rearrangements, such as duplications, deletions,
and insertions, may occur in cells as a result of mech-
anisms that have evolved for the repair of DNA damage.
Homologous recombination and nonhomologous end
joining (NHEJ) are the two major types of repair mech-
anisms (Kanaar et al. 1998; Tsukamoto and Ikeda
1998). These pathways differ in their accuracy. Ho-
mologous recombination mechanisms ensure accurate
repair by using homologous sequence as a template.
Conversely, NHEJ is an error-prone mechanism that
uses limited sequence homology or none at all (Roth et
al. 1985; Roth and Wilson 1986). Junctions formed by
NHEJ typically have microhomology, insertion, or de-
letion of a few base pairs of DNA (Lieber et al. 2003).
The nonrandom distribution of rearrangements in the
genome suggests that DNA sequence and genomic ar-
chitecture can predispose certain regions to chromo-
somal instability. Speciﬁc sequences and structures have
been implicated, including low-copy repeats (LCRs)
(usually 10–500 kb in size, with 95%–98% homology)
(Stankiewicz and Lupski 2002), inverted repeats (Chu-
zhanova et al. 2003), palindromic AT-rich sequences
(Edelmann et al. 2001; Kurahashi et al. 2003), and mo-
tifs involved in recombination (Abeysinghe et al. 2003).
Charcot-Marie-Tooth disease type 1A (CMT1A) and
other genomic diseases described to date mostly occur
by nonallelic homologous recombination (NAHR) me-
diated by LCRs (Lupski et al. 1991; Chance et al. 1994;
Lupski 1998; Perez Jurado et al. 1998; Christian et al.
1999; Edelmann et al. 1999; Inoue and Lupski 2002;
Shaw and Lupski 2004).
In this study, we have determined the location and
size of the Xq22 duplications in a cohort of 59 patients
with PMD who have an increased dosage of the PLP1
gene. To identify structures and motifs causing the ge-
nomic instability and to determine whether the dupli-
cations occurred by homologous or nonhomologous
mechanisms, we mapped the proximal and distal du-
plication breakpoints and sequenced the duplication
junctions from 13 of these individuals with tandem du-
plications. Our results suggest that tandem head-to-tail
Xq22 duplications in patients with PMD were formed
by coupled homologous and nonhomologous recom-
bination, rather than by NAHR like the common re-
arrangements associated with other genomic disorders.
Material and Methods
Patients
Peripheral blood samples, lymphoblastoid cell lines,
or both were obtained from 59 patients with PMD from
different families who were found to harbor PLP1 du-
plications by FISH or multiplex PCR (data not shown).
This study was approved by the local ethics committees
at the Institute of Child Health and the Alfred I. duPont
Hospital for Children, and informed consent was ob-
tained appropriately.
Mapping Strategy
Metaphase FISH was performed on a subset of the
patients to conﬁrm that the duplication was within
Xq22. In the laboratory at the Institute of Child Health,
the extent of duplication was mapped using several
complementary methods. Most patients studied in this
laboratory were examined by both interphase FISH
and multiplex PCR (24/28 patients), and two of these
were also characterized by ﬁber FISH (patients PMD9
and PMD24). The exceptions were three patients who
were investigated only by PCR (PMD23, PMD30, and
PMD42) and one patient who was screened only by
FISH (PMD45). In the laboratory at the duPont Hos-
pital, the extent of duplication was determined solely by
multiplex PCR, but a different method was used. Re-
producibility of the different mapping strategies was
conﬁrmed by three samples mapped by both laboratories
independently. Further validation of mapping methods
was obtained by testing 49 samples from both labora-
tories with the use of a third multiplex PCR approach.
FISH Analysis
FISH was performed as described elsewhere (Wood-
ward et al. 2003). Cosmid, BAC, or PAC genomic clones
were selected from the Ensembl Genome Browser Web
site (Hubbard et al. 2002) and were obtained from the
Wellcome Trust Sanger Institute (Hinxton, United King-
dom) (see The Wellcome Trust Sanger Institute: Human
X Project Web site). Metaphase chromosomes and in-
terphase nuclei from patient lymphoblastoid cell lines
were cultured and harvested in accordance with stan-
dard protocols. DNA ﬁbers were prepared from lym-
phoblastoid cell culture by use of a protocol available
at The Wellcome Trust Sanger Institute: DNA Fibers
Web site. DNA is not stretched uniformly using this
method, and, therefore, inferences about signal size can
be made only on the basis of comparison with other
signals on the same ﬁber, since different ﬁbers may be
stretched to different degrees.
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Table 1
Primer Sequences Used in Mapping
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Multiplex PCR
Primers were designed using the human genome se-
quence (Ensembl and National Center for Biotechnology
Information [NCBI] Web sites) and the Primer3 pro-
gram, MacVector software (Accelrys), or inspection of
the sequence. Primer sequences spanning ∼7.4 Mb from
position 99.40 Mb to position 106.80 Mb on the X
chromosome (Ensembl v29.35b; NCBI build 35), lying
3.4 Mb proximal and 4 Mb distal to PLP1, are shown
in table 1. Several multiplex PCR approaches were used.
The approach used in the laboratory at the Institute of
Child Health was universal-primer quantitative ﬂuores-
cent multiplex (UPQFM)–PCR (Heath et al. 2000),
which involved two PCR reactions. The primary reac-
tion ampliﬁed selected sequences by using unique prim-
ers with a universal tag. A typical reaction included three
primers pairs around each of the breakpoints to be an-
alyzed, a PLP1 exon 6 probe expected to be duplicated
(primers PLP6F and PLP6R), and a control autosomal
locus from the cystic ﬁbrosis gene (CF) (CFF and CFR).
The secondary reaction ampliﬁed the products from the
ﬁrst reaction by using universal primers with a ﬂuores-
cent dye at the 5′ end (UNIVF and UNIVR). PCR prod-
ucts were separated on an ABI 377 DNA sequencer, and
the relative amounts of the ampliﬁed peak areas were
determined using Genotyper software (Applied Biosys-
tems) and were compared with ratios obtained from nor-
mal controls and control duplication patients. For amale
with a PLP1 duplication, the expected ratio value for a
single-copy sequence, compared with PLP1, is 0.5, and
the expected value for a duplicated sequence is 1. When
the autosomal CF locus is used as a control, the male
ratio expected for a nonduplicated sequence is 1, com-
pared with a ratio of 2 for a duplicated sequence.
The multiplex PCR approach used in the duPont Hos-
pital laboratory for all breakpoint mapping was ampli-
ﬁcation of a region in or near PLP1 with a region of
the dystrophin gene on Xp (hDys26F and hDys26R or
hDys23F labeled with ﬂuorescent dye and hDys23R).
The PCR reactions were performed with 50 ng genomic
DNA in a 25-ml reaction by adding Taq Buffer (5# Taq
Buffer is 83 mM Tris-HCl [pH 8.8], 850 mg/mL BSA,
83 mM (NH4)2SO4, 33.5 mM MgCl2, 34 mM EDTA,
and 50mM b-mercaptoethanol), 5%dimethyl sulfoxide,
12.5 pmol of each primer, 1.5 mM dNTPs, and 0.625
U AmpliTaq (Applied Biosystems). The conditions were
as follows: melting at 94C for 5 min; 25 cycles at 94C
for 30 s, 55C for 30 s, and 65C for 1 min; and a ﬁnal
extension at 65C for 6 min. Detection and quantitation
of products ampliﬁed with unlabeled primers used eth-
idium bromide–stained 4% NuSieve 3:1 agarose gels
(Cambrex BioScience) and an Eagle Eye II gel docu-
mentation systemwith Eagle Sight software (Stratagene).
Alternatively, labeled primers were used, allowing de-
tection by capillary electrophoresis on an ABI Prism 310
Genetic Analyzer with Genescan software (Applied Bio-
systems). For a male patient, if the region being tested
is duplicated, the expected normalized ratio of the region
to the dystrophin control is 2, and, if it is not duplicated,
the expected ratio is 1.
A third multiplex PCR approach was performed in
the duPont Hospital laboratory to validate use of the
dystrophin internal control primers in the previous ap-
proach and to determine whether the mapping ap-
proaches used in the two laboratories gave reproducible
results. The Multiplex PCR Kit (Qiagen) was used in
accordance with the manufacturer’s instructions for
multiplex ampliﬁcation with unlabeled primers for a re-
gion of the PLP1 gene (PLP7F2 and PLP7R), a region
of dystrophin (hDys26F and hDys26R), a region of the
cystic ﬁbrosis transmembrane receptor gene on chro-
mosome 7 (HCFTR-4F and HCFTR-4R), two regions
proximal to PLP1 that are expected to be duplicated in
some patients and not in others (421I20-F5 and 421I20-
R5; 1055C14-F7 and 1055C14-R7), and two distal
regions (540A13-F3 and 540A13-R3; 461C10-F6 and
461C10-R6). Detection and quantitation of products
used ethidium bromide–stained 4% NuSieve 3:1 aga-
rose gels (Cambrex BioScience) and a Gel Logic 440
Imaging System with accompanying molecular imaging
software (Eastman Kodak).
Ampliﬁcation and Sequencing of Duplication Junctions
Long-range PCR (LR-PCR) by the Expand High Fi-
delity PCR System (Roche) was used to amplify junction
breakpoints in 11 patients whose proximal and distal
breakpoints were mapped by either multiplex PCR or
ﬁber FISH. A forward primer from the distal region and
a reverse primer from the proximal region were used to
generate a junction product in the patient that was not
present in normal control individuals. For breakpoints
mapped to within 2–9 kb by multiplex PCR, LR-PCR
was performed using proximal and distal primers de-
duced to be within the duplication. For breakpoints
mapped by FISH, several primers were designed from
both the proximal and the distal breakpoint regions
identiﬁed, and these were used in different combinations
until a unique product was generated.
LR-PCRwas unsuccessful for patients P026 and P134;
therefore, a standard protocol was used for inverse PCR
(IPCR) (Triglia et al. 1988). This required restriction
digestion of genomic DNA with PstI and XbaI for P026
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Table 2
Primer Used for Ampliﬁcation of Duplication Junction
Fragments by LR-PCR in 13 Patients with PMD
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
and P134, respectively; DNA ligation at low concentra-
tions; and then PCR ampliﬁcation using primers de-
signed in a divergent direction near the proximal du-
plication breakpoint. The LR-PCR and IPCR products
were excised from 1% agarose gels and were puriﬁed
using a gel extraction kit (Qiagen).
Primers used to amplify across the junction by LR-
PCR or IPCR are listed in table 2. These fragments were
gel puriﬁed, and nested primers were used at one or both
ends to generate smaller fragments and sequences across
the junction. DNA sequencing was performed using the
ABI Prism BigDye v3.1 terminator kit and an ABI 377
DNA sequencer (Applied Biosystems).
Bioinformatics and Sequence Analysis
of the Duplication Breakpoint Regions
Information available from Ensembl, the UCSC Ge-
nome Browser, and the NCBI Web site was used for
selection of FISH clones, design of PCR primers, and
identiﬁcation of genes in duplicated regions. Information
presented is from Ensembl v29.35b, based on NCBI
build 35. Data from our FISH studies, multiplex PCR
studies, and junction analyses were compiled in a Mi-
crosoft Access database, which was used to format the
data for uploading and displaying in Ensembl.
Various Web-based sequence-analysis programs were
used to investigate the 13 tandem duplication events (see
Web Resources). By use of BLASTn (Altschul et al.
1990), with the recombinant junction sequence as the
query sequence, the exact positions of the proximal and
distal breakpoints were conﬁrmed on Xq22 and within
speciﬁc genomic clones. The breakpoints represent the
boundaries between single-copy and duplicated DNA
sequences, and the genomic segments surrounding each
breakpoint were investigated and termed “breakpoint
regions.” Reference genomic sequences were obtained
from Ensembl and UCSC on the basis of breakpoint
position. CLUSTALW was used to align the abnormal
recombinant junction sequence determined from each
duplication event, with the reference genomic sequence
from both the proximal and distal breakpoint regions.
BLASTn was also used for analysis of sequence homol-
ogies, with the use of genomic segments ∼70 bp in size
and centered on the DNA breakpoints. Pairwise se-
quence comparisons of the 2-kb proximal and distal
breakpoint regions for each patient were performed us-
ing BLAST2 with default parameters (Tatusova and
Madden 1999). These 2-kb sequences were also ana-
lyzed for repetitive elements and low-complexity se-
quences by use of RepeatMasker (RepBase database ver-
sion 7.4). Reﬁned computer-based sequence analysis
included the screening for tandem and palindromic in-
verted repeats in 300-bp breakpoint regions by use of
Mreps and Palindrome, respectively. Purine and pyrim-
idine repeats 10 bp, which equates to roughly one
helical turn of DNA (Ussery et al. 2002), were identiﬁed,
and only perfect uninterrupted tracts were included. We
used Mfold version 3.1 (Zuker 2003) for prediction of
secondary structures, analyzing 30 bp across each prox-
imal and distal breakpoint and comparing those se-
quences with the 30-bp recombinant junction sequence.
Finally, we used DNA Pattern Find to search for 36
speciﬁc sequence motifs elsewhere implicated in DNA
rearrangements (Abeysinghe et al. 2003). We compared
the results obtained from the 30-bp breakpoint regions
(i.e., 15 bp on each side of the breakpoint) with control
DNA sequences the same size found 150 bp proximal
to each respective breakpoint. The close proximity was
chosen to minimize variation in sequence properties due
to genomic location.
LCR segments of DNA in a 2-Mb region around the
PLP1 gene were investigated using PipMaker (Schwartz
et al. 2000). The boundaries of the various repeat
elements identiﬁed were determined using BLAST,
CLUSTALW, and RepeatMasker.
Results
Characterization of 59 Duplication Events on Xq22
and Mapping Breakpoints
The extent of the duplications in 59 patients with
PMD was determined by interphase FISH and multiplex
PCR using clones and primers throughout a 7.4-Mb re-
gion including the PLP1 gene. The combined mapping
data for each patient were displayed in Ensembl (ﬁg. 1).
Of the 59 duplication events studied, 38 were inherited
from carrier female mothers, 20 had unknown inheri-
tance patterns, and 1 was shown by FISH to be a de
novo event in the patient (K.J.W. andM.C., unpublished
data).
Metaphase FISH for 39 patients, with the use of PLP1
and ﬂanking probes, showed that the majority (36/39
cases) had duplicated regions within Xq22. Three pa-
tients had a PLP1 duplication located elsewhere in the
genome: Xq26 in patient PMD1 (Woodward et al.
2003), Xp22 in PMD5 (Hodes et al. 2000), and the Y
chromosome in P149/PMD46 (K.J.W. and M.C., un-
published data). Patient P015 had an additional dupli-
cated region that was proximal to the PLP1 duplication,
and patients P307 and P389 had an additional distal
duplication. Breakpoint locations for these additional
duplications are shown in ﬁgure 1.
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Figure 1 Breakpoint analysis in 59 patients with PLP1 duplications. Duplication mapping information gained by FISH, multiplex PCR,
LR-PCR, and IPCR and uploaded into Ensembl is shown. Horizontal bars indicate duplicated regions in each patient; the unblackened region
is duplicated, and breakpoints are located within the blackened ends. The resolution of breakpoint mapping varies among patients because of
the different methods used (FISH vs. PCR) and because of the number of PCR primer pairs analyzed in each case. The location of PLP1, which
lies at position 102837923–102853693 bp (102.8 Mb) on the X chromosome (Ensembl v29.35b; NCBI build 35), is indicated by a red vertical
line. Breakpoint junctions have been sequenced for the 13 patients listed in red (see ﬁg. 2). A block of LCRs distal to PLP1 is indicated by a
black-outlined vertical rectangle. Duplications mapped by metaphase FISH within Xq22 are indicated by an asterisk (*). Duplications mapping
to other regions are indicated by a horizontal arrow. The location of relevant clones, markers, and Ensembl genes is indicated at the bottom.
Patients indicated by “PMD” and a number or by “P” and a number were studied at the Institute of Child Health or the Alfred I. duPont
Hospital for Children, respectively. The duplications of three patients—P176/PMD7, P083/PMD38, and P149/PMD46—were mapped by both
groups, and the mapping information generated was in agreement, providing evidence that methods in the respective laboratories gave equivalent
results. Multiplex PCR ampliﬁcation performed on DNA from 49 of the patients, by use of primers speciﬁc to two proximal and two distal
regions ﬂanking PLP1 along with primers for an autosomal region and an X-chromosomal region, veriﬁed the reproducibility of the mapping
methods used by the two laboratories and validated the use of an X-chromosomal control region in mapping. Families reported elsewhere
include PMD1 (Woodward et al. 1998, 2000, 2003; Hodes et al. 2000); PMD2 (Ellis and Malcolm 1994; Harding et al. 1995; Woodward et
al. 1998, 2000); PMD9 (Ellis and Malcolm 1994; Woodward et al. 1998, 2000); PMD5 (Hodes et al. 2000; Woodward et al. 2000); PMD3,
PMD4, PMD6, and P176/PMD7 (Woodward et al. 2000); PMD24 (Woodward and Malcolm 1999); PMD27 (Sistermans et al. 1998); and
P116 (Watanabe et al. 1973; Wilkus and Farrell 1976). In four cases—PMD27, PMD31, PMD6, and PMD8—the extent of the duplication
was determined in a female carrier because there was insufﬁcient material from the male patient with the duplication.
The duplications including PLP1 ranged in size from
100 kb to 4.6 Mb, with variability at both the proximal
and distal breakpoints. Patients PMD45 and P110 had
the largest duplications. The duplication in patient
PMD45 extended the farthest proximal to PLP1,
whereas the duplication in patient P110 extended the
farthest distal to PLP1. Interestingly, we found that the
duplicated genomic segments in each of the 59 patients
were unique. Clustering of the distal duplication break-
point was apparent. Most patients had breakpoints
within a 430-kb region distal to PLP1, and approxi-
mately one-half of the patients had a DNA break within
a 200-kb genomic segment of distal LCR sequences (ﬁg.
1). The exceptions were patients PMD45, PMD43,
P176/PMD7, and P110, who had the largest duplica-
tions. A less clustered distribution of proximal break-
points was observed to lie within a 750-kb region prox-
imal to PLP1. All but one patient (PMD45) had the
proximal breakpoint in this region.
In four families examined, the extent of the duplica-
tion determined in the patient was the same as that found
in a female carrier, suggesting that the duplication had
been stably inherited. This justiﬁed the assumption
about carriers PMD27, PMD6, and PMD8 that the du-
plication would be identical to that inherited by the pa-
tients. However, the possibility of an alteration in the
conﬁguration of the rearrangement during meiosis can-
not be excluded.
Fine Mapping of Breakpoints and Sequencing
of Duplication Junctions
Because it had been demonstrated previously that
most PMD duplications are head-to-tail in orientation,
we began ﬁne mapping of proximal and distal break-
points—that is, the regions between single-copy and du-
plicated sequence (the boundary A/B1 and the boundary
D2/E in ﬁg. 2)—with the aim to PCR amplify and se-
quence across the abnormal junctions formed by the
tandem duplications (the boundary D1/B2 in ﬁg. 2). Note
that, at these junctions, sequence on the centromeric side
is from a more distal portion of the human genome
reference sequence (D1 in ﬁg. 2) than is sequence on the
telomeric side of the junction (B2 in ﬁg. 2), so that distal
clones are abnormally juxtaposed to proximal ones. We
mapped and sequenced 13 duplication junctions.
We used ﬁber FISH for high-resolution mapping of
the breakpoints for patients PMD24 and PMD9 (ﬁgs. 3
and 4) and LR-PCR for ampliﬁcation of the duplica-
tion junctions. For 11 patients, the proximal and distal
breakpoint positions were reﬁned by multiplex PCR and
were ampliﬁed by LR-PCR or IPCR. The junction se-
quences obtained (ﬁg. 5) were analyzed by BLASTn
searches to conﬁrm the precise breakpoint locations on
Xq22 (table 3). Attempts to ﬁnd junctions in patients
P113, P119, and P379 by both LR-PCR and IPCR and
in P130, PMD10, PMD34, PMD3, and P290 by LR-
PCR failed despite equally well-mapped breakpoints, for
unknown reasons. The remaining duplications were not
mapped at a resolution high enough to attempt to iden-
tify junctions.
Most of the junction sequences were consistent with
the positions predicted by interphase FISH andmultiplex
PCR and with simple tandem head-to-tail duplication,
although subtle rearrangements could not be ruled out.
However, sequence analysis of the junctions identiﬁed
in patients P134 and P255 (ﬁg. 5) revealed sequences
that were 41.5 kb and 99 kb proximal, respectively (ﬁg.
6A and 6B), to the multiplex PCR-predicted locations.
Interestingly, the distal sequence at the junction in pa-
tient P255 was in an inverse orientation compared with
what would be expected for a tandem head-to-tail du-
plication (clone Z70227 in ﬁg. 6B). In addition, align-
972 Am. J. Hum. Genet. 77:966–987, 2005
Figure 2 Generalized duplication structure for tandem PLP1 duplications. Single-copy sequence proximal and distal to the duplication
is shown as A and E, respectively. Double-copy sequence is shown as BCD and as an arrow. We have not distinguished between B1C1D1 and
B2C2D2 in our patients; one represents the normal Xq22 sequence, and the other is the duplicated sequence. The PLP1 gene is shown as a
blackened oval. At the junction, sequences 5′ of the distal duplication breakpoint become adjacent to sequences 3′ of the proximal duplication
breakpoint, generating a structure not found in control individuals (region D1/B2). The boundaries of the duplicated and single-copy sequences
have been designated as the breakpoint regions; the proximal breakpoint region is A/B1, and the distal breakpoint region is D2/E.
ment of junction sequence from patient P083 with the
reference human genome sequence (ﬁg. 5) revealed two
potential distal breakpoint sequences (indicated by as-
terisks [*] in ﬁg. 6C). The distal breakpoint was pre-
dicted by multiplex PCR to be in a long interspersed
nuclear element (LINE) in clone AL139228, and most
of the sequence obtained at the junction matched this
clone, but there were ﬁve mismatches in the ﬁrst 55 bases
at the junction. These 55 bases matched exactly those
in a LINE in the reverse orientation and 81 kb distal in
clone AL139229.
Analysis of Breakpoints
Either the proximal or distal boundary between single-
copy and duplicated sequence (region A/B1 or D2/E, re-
spectively, in ﬁg. 2) has to be formed during the re-
arrangement process by which a tandem head-to-tail
duplication is formed. Thus, we ampliﬁed and sequenced
across both of these boundaries by PCR in four patients
(P176, P114, an affected relative of P116, and P348).
Identical sequences were revealed when the boundary
sequences were compared with the reference genomic
sequences by use of BLAST2 (not shown), suggesting
that one end of the duplication was formed by an error-
free homologous recombination mechanism.
Known genes or Genscan gene predictions were found
to be interrupted at the junctions in several patients (ta-
ble 3). No signiﬁcant phenotypic differences have been
noted in these patients during clinical evaluation to date.
Bioinformatics Analysis of Proximal and Distal
Breakpoints
No signiﬁcant homologies were revealed when the
recombinant junction sequence from each duplication
event was aligned with the reference genomic sequence
at the proximal and distal breakpoints. Most patients
had minimal sequence identity in the 30 bp surrounding
each breakpoint and only short overlaps or microho-
mologies of 1–6 bp at the junction (ﬁg. 5). One patient
(P015) had a 2-bp insertion that was not present in either
clone.
A comparison of larger genomic clone segments (2
kb) from the proximal and distal breakpoint regions of
each patient identiﬁed no sequence similarities for 11 of
the 13 tandem duplications. In contrast, sequence sim-
ilarities between the 2-kb breakpoint regions were iden-
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tiﬁed for P116 and P110. For P116, almost the whole
sequence on both sides of the junction was composed
of interspersed repetitive elements (see table 3). Similar-
ity was detected between a nearly complete AluSg ele-
ment at the distal breakpoint and a partial AluJo repeat
65 bp beyond the proximal breakpoint. There were no
regions of similarity extending 17 bp beyond the Alu
elements. Only a 3-bp overlap was observed at the junc-
tion when the two breakpoint sequences were aligned
(ﬁg. 5). In P110, we found an exact 6-bp match at the
junction and further sequence identity in the ﬂanking
region (ﬁg. 5). RepeatMasker revealed that both break-
points were embedded within Alu elements, with the
proximal repeat an AluYc2 and the distal repeat an
AluSg. The proximal and distal breakpoint regions
showed a high level of homology across the junction,
with a chimeric AluYc2-AluSg element formed at the
junction, but the homology did not extend beyond the
interspersed repetitive elements. A second signiﬁcant
homology within the 2-kb breakpoint region was identi-
ﬁed between the AluYc2 proximal breakpoint sequence
and an AluSx element immediately 5′ of the distal
breakpoint.
Analysis of Breakpoint Features and Flanking Region
for 13 Sequenced Duplication Junctions
RepeatMasker (RepBase version 7.4) revealed inter-
spersed repetitive elements, including Alu elements,
LINEs, or long terminal repeats (LTRs), either unilat-
erally or bilaterally in 12 of the 13 sequenced duplication
events (table 3). The exception was patient P255, who
had unique sequence at both the proximal and the distal
ends. Examination of each of the breakpoints individ-
ually showed Alu elements at seven junctions, LINEs at
seven junctions, LTR elements at four junctions, and
unique sequence at eight junctions. Six patients had
breaks within Alu elements (table 3), and all but two of
these elements (P114 distal and P224 proximal) were
almost full length. The breaks appeared to have a ran-
dom distribution, and none were within the 26-bp core
consensus sequence at the 5′ end of Alu elements (Dein-
inger et al. 1981; Rudiger et al. 1995). The nearest were
20 bp away in patient P224 and 16 bp away in patient
P134. Six patients had breaks within L1 LINEs (table
3). These elements were mostly partial in length, and
the breaks appeared to have a random distribution. Al-
though breakpoints often coincided with Alu elements,
LINEs, or LTRs, not all breakpoints mapped to intervals
of heavy interspersed repeat content. The percentage of
interspersed repetitive DNAwithin the 2 kb surrounding
each breakpoint varied from 0% to 100%, with an
average value of 54.6%, corresponding to 65.8% at
the distal breakpoints and 43.4% at the proximal
breakpoints.
Tandem repeats of purine, pyrimidine, or alternating
purine/pyrimidine tracts were found either unilaternally
(6/13) or bilaterally (6/13) within 12 of the 13 dupli-
cation events. Patient P134 was the exception, with no
tracts identiﬁed at either breakpoint. Pyrimidine tracts
were in the greatest abundance, with more found at the
proximal breakpoints (6 distal and 15 proximal). There
were equal numbers of purine tracts (7 distal and 3 prox-
imal) and alternating purine/pyrimidine tracts (4 distal
and 6 proximal). Seven patients had tracts very close to
the junction breakpoints, and these are shown in the
CLUSTALW alignments (ﬁg. 5). Patient PMD9 had a
purine tract of 11 bp spanning the distal breakpoint,
and patient P083 had an alternating purine/pyrimidine
tract of 12 bp positioned 2 bp from the proximal break-
point. The longest tract was a 32-bp purine sequence
positioned 5 bp from the distal breakpoint in P348 but
not present in the junction. Additional tandem repeats
with different nucleotide compositions were identiﬁed in
ﬁve patients (P114, P110, P083, P348, and P026). The
longest was 37 bp in length and spanned the proximal
breakpoint and junction in patient P348. The repeat was
composed of 2.31 copies of a 16-bp sequence (ATCTCA-
GCTCACTGCA; shown by arrows in ﬁg. 5). The others
were 16 or 17 bp in length and were located 130 bp
from the breakpoint junction and therefore are not
shown in the CLUSTALW alignment (ﬁg. 5).
Palindromes (10 bp) were found in only four du-
plication events (in patients P176, P114, P255, and
P348), and the two found within proximal breakpoint
sequences are also present in the junction (P176 and
P114). The palindrome closest to the junction break-
point and therefore included in the CLUSTALW align-
ment (ﬁg. 5) was within the pyrimidine tract (Y32) in
P348. We used Mfold to investigate the role of DNA
secondary structure in mediating the duplication event.
In all patients except P015, the secondary structures for
the junction were less stable than the original breakpoint
sequences, which suggests that they are not involved in
promoting the rearrangement. Furthermore, our com-
puter-based analysis for 37 short sequence motifs pre-
viously associated with chromosomal rearrangements
and possibly involved in DNA cleavage and recombi-
nation (Abeysinghe et al. 2003) found no differences
between the breakpoint and control regions and did not
reveal a common mechanism (data not shown).
Topoisomerase I consensus cleavage sites (CAT, CTY,
GTY, and RAT) (Been et al. 1984) were frequently found
near every breakpoint for each of the 13 duplication
events. Since there were two possible distal breakpoints
for patient P083, a total of 27 breakpoint and control
sequences were investigated. We found an average of six
topoisomerase I sites within the breakpoint sequences
and seven within the control sequences, 150 bp away,
and thereby concluded that the difference was not sig-
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Figure 3 Fiber FISH mapping of duplication breakpoints in patient PMD24. A, Relative sizes and positions of distal and proximal
breakpoint clones used for ﬁber FISH, as shown in Ensembl. Interphase FISH had previously mapped the distal breakpoint within AL135959
and AL049631 and the proximal breakpoint within AL133348 and Z92846. B, Composite image of ﬁber FISH of normal cell lines, showing
the relationship between distal and proximal breakpoint clones. Underneath each ﬁber FISH image is a representation of the relationship between
these clones, as deduced from the ﬁber FISH data. The color of the box for each clone corresponds to the color in the FISH image. C, Fiber
FISH of PMD24 ﬁbers by use of the distal and proximal clones expected to contain the duplication breakpoint. Juxtaposed signals for AL135959
and Z92846 in the patient are shown. Signals for these clones were widely separated in normal controls and showed no relationship (data not
shown). These clones are normally located ∼800 kb apart and clearly demonstrate that the duplication was tandem in nature. D, Arrows show
the likely position of both breakpoints, on the basis of ﬁber FISH data. Since only a short red hybridization signal was observed in junction
ﬁbers as opposed to normal ﬁbers, we estimated that the breakpoint is in the proximal half of clone Z92846. In contrast, the length of the
green signal was almost the same in junction and normal ﬁbers, suggesting that the breakpoint was toward the end of clone AL135959.
E, Probable orientation of clones relative to the breakpoint (dashed line). The images shown are composites of several different ﬁbers from the
same experiment, but only four individual ﬁbers are shown from each hybridization, for simplicity. The ﬁbers shown are representative of the
images captured from each slide.
niﬁcant. We found no topoisomerase II consensus cleav-
age sites and no other sequence motifs that were
consistently present at each breakpoint. The DNA
polymerase a pause site core sequence (GAG) was found
at 21 of the 27 breakpoints but was equally common
within the control sequences.
Analysis of the 2-Mb Region Surrounding PLP1
for LCRs
We analyzed the 2-Mb region surrounding PLP1 for
LCRs. Three small regions of similarity were identiﬁed
on each side of PLP1 (shown by triangle, square, and
circle symbols in ﬁg. 7A), and these were short (86–
3,197 bp), with a low percentage identity (table 4). In-
vestigation using BLASTn revealed no similarities be-
tween the repeats and other regions of the human
genome. None of the patients had both proximal and
distal breakpoints that coincided with the positions of
these ﬂanking repeats; therefore, they were not consid-
ered to have a major role in generating the duplications.
Thus, the PMD duplications are not mediated by ho-
mologous LCRs at proximal and distal breakpoints
(NAHR).
A large LCR region distal to PLP1 was also found
that had a complicated repeat structure (shown by a
horizontal oval symbol in ﬁg. 7A). We identiﬁed two
directly repeated LCRs, LCR-PMDA (comprising Ala
[20.3 kb] and A2 [11.7 kb]) and LCR-PMDB (com-
prising A3 [14.8 kb] and Alb [20.3 kb]), that have been
described elsewhere, and both contain a pair of inverted
repeats with a high degree of sequence identity (88.1%)
(Inoue et al. 2002). In addition, we found a novel pair
of inverted repeats, termed “LCR-PMDC” and “LCR-
PMDD,” which are 35.6 kb and 27.7 kb in length and
lie on either side of LCR-PMDA and LCR-PMDB (ﬁg.
7B), making the entire distal LCR region almost 200 kb
in length. The LCR-PMDC and LCR-PMDD repeats are
also very similar to each other, since comparison using
BLASTz showed 92.4% sequence identity over a region
25 kb in size. They are not similar to LCR-PMDA and
LCR-PMDB. In addition, we identiﬁed a few small
regions of similarity to LCR-PMDA and LCR-PMDB
lying proximal to the main LCR region, within genomic
clones AL390022 and Z70273 (ﬁg. 7B), and also present
∼164 kb proximal to PLP1 in clone Z73965 (104 bp,
with 73.08% identity with LCR-PMDA and LCR-
PMDB) (see vertical oval symbol in ﬁg. 7A).
The region proximal to PLP1 contained numerous
short locally repeated sequences that had an alternating
distribution, indicated by the checkerboard-like pattern
in ﬁgure 7A. Further investigation of these repeated
regions found that there were four different types of
repeat sequences proximal to PLP1. Although these
proximal repeats covered a wider area than the distal
repeats, individual repeat units were generally much
shorter (mean size ∼6 kb). Between repeat units within
each of the four proximal groupings there was less sim-
ilarity than that found for the distal LCRs. Most showed
only 60%–80% similarity in BLASTz comparisons.
Many of the repeats included coding sequences, and the
majority of the annotated genes in the 1-Mb region prox-
imal to PLP1 were contained within a repeat unit. The
relatively low degree of sequence identity between the
various copies of the proximal repeats makes it seem
unlikely that NAHR-based rearrangements between dif-
ferent copies of these proximal repeats would be likely
to occur. However, the presence of numerous repeats in
this region suggests that duplications within this region
have occurred repeatedly in the past, and it may indicate
a tendency toward duplication events in this region.
Discussion
Our molecular dissection of Xq22 rearrangements in 59
patients with PMD has provided insights into the mo-
lecular mechanisms of chromosome duplication. We
have found unique duplication structures for each pa-
tient and widely scattered breakpoints, especially at the
proximal end. Interestingly, however, there is some clus-
tering of breakpoints at the distal end. Analysis of the
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Figure 4 Fiber FISHmapping of duplication breakpoints in patient PMD9.A,Relative sizes and positions of distal and proximal breakpoint
clones used for ﬁber FISH, as shown in Ensembl. Interphase FISH and UPQFM-PCR mapped the proximal breakpoint to a 12-kb interval
within AL035494 and Z81014 but gave contradictory results for the distal breakpoint, which mapped within a reported LCR (Inoue et al.
2002). B, Fiber FISH of normal cell lines, showing the relationship between distal and proximal breakpoint clones. The color of the box for
each clone corresponds to the ﬂuorescent label used in the hybridization and the position indicated by ﬁber FISH. Genomic clones Z70227 and
AL034485 from the distal region identiﬁed by UPQFM-PCR showed two signals of similar size lying next to each other without any overlap.
However, there was an additional smaller signal from Z70227 (red) present at the other end of the AL034485 signal (green). The majority of
the DNA sequence for clone AL034485 and the distal part of Z70227 contains inverted repeat sequences (A1a and A2) as part of LCR-PMDA
(see ﬁg. 7B). Therefore, the extra signal probably represents hybridization of Z70227 to part of the A2 repeat unit. The same patterns were
observed for both normal and PMD9 ﬁbers. Overlapping signals for the two proximal clones, AL035494 and Z81014, were observed in normal
and patient ﬁbers, with the smaller signal from the cosmid Z81014 almost entirely contained within the longer AL035494 signal (green).
C, Four ﬁber FISH experiments on PMD9 ﬁbers, each combining different distal (Z70227 or AL034485) and proximal (Z81014 or AL035494)
clones. Underneath each ﬁber FISH image is a representation of the relationship between these clones, as deduced from the ﬁber FISH data.
The color of the box for each clone corresponds to the color in the FISH image. As expected, no relationship between clones was observed in
normal controls (data not shown), but a consistent pattern was seen for patient PMD9. D, The likely position of both breakpoints (arrows),
on the basis of ﬁber FISH data. When distal clone Z70227 was cohybridized with proximal clone Z81014 or AL035494, a gap was seen
between the signals, and the Z70227 signal (red) appeared to be longer than the Z81014 signal (green) and of a similar size to the AL035494
signal. Since there is a large overlap between these two proximal clones, and since they both appeared to be the same size as AL034485 at the
breakpoint, it seemed likely that the proximal breakpoint was near the sequence junction between AL035494 and Z81014. When distal clone
AL034485 was used in the ﬁber FISH experiments, signals adjacent to either of the two proximal clones were observed. This was consistent
with the distal duplication breakpoint lying within the proximal part of AL034485, since the junction signals for this clone appeared relatively
short. The ﬁber FISH data supported the UPQFM-PCR breakpoint mapping. The location of LCR-PMDA and inverted repeat sequences (A1a
and A2) are shown with respect to the breakpoint. E, The probable orientation of clones relative to the breakpoint (dashed line). The ﬁber
images shown are composites of several different ﬁbers from the same experiment, but only 4–5 individual ﬁbers are shown from each
hybridization, for simplicity. The ﬁbers shown are representative of the images captured from each slide.
2-Mb region surrounding PLP1 revealed no large LCRs
ﬂanking the gene but a distal LCR region with a com-
plicated structure containing both inverted and direct
repeats. We identiﬁed two novel LCRs, named “LCR-
PMDC” and “LCR-PMDD,” that are similar in se-
quence to each other but not to LCR-PMDA and LCR-
PMDB, which were reported elsewhere (Inoue et al.
2002). The ﬁnding of novel LCRs extends the LCR re-
gion to ∼200 kb, and almost one-half of the distal break-
points are within this region. Interestingly, a region with
similarity to the distal LCR region was found proximal
to PLP1 in Z73965, but it was small, with low identity,
and could not account for all the different proximal
breakpoints. However, many small repeat sequences
with minimal homology and unrelated to the distal
LCRs were identiﬁed proximal to PLP1.
Sequence analysis of the junctions of 13 tandem du-
plications (D1/B2 in ﬁg. 2) showed an insertion or mi-
crohomology of 1–6 nt in the majority of events but no
long stretches of homology. Sequence analysis of the
boundaries between single-copy and duplicated se-
quence at the proximal and distal breakpoints (regions
A/B1 and D2/E in ﬁg. 2) of four tandem duplications
showed no variation from the reference genomic se-
quence. Taken together, these data suggest that the
mechanism of NAHR between LCRs does not occur in
the majority of patients with PMD, in contrast to those
with CMT1A and many other genomic diseases (Lupski
1998; Inoue and Lupski 2002), and the data also suggest
that PLP1 duplications are formed by a coupled ho-
mologous and nonhomologous mechanism. The obser-
vation of normal reference genomic sequence at one end
of the duplicated region, either the proximal or the distal
breakpoint, suggests an error-free homologous repair
process. Because both of the sequences are normal at
these breakpoints, it is not possible to tell which had
been involved in formation of the duplication. There-
fore, in our structure of a tandem duplication event
illustrated in ﬁgure 2, we cannot determine whether
B1C1D1 or B2C2D2 is the duplicated sequence. Since
PLP1 duplications predominantly occur on the paternal
X chromosome (Mimault et al. 1999), the sister chro-
matid would be used as template for the homologous
repair, a common occurrence in mammalian cells (John-
son and Jasin 2000). The abnormal junction with an
insertion, a deletion, or microhomology at the other end
of the duplicated region suggests a nonhomologous re-
pair process. Such features are reported to occur fre-
quently at nonhomologous junctions (Domer et al.
1995; Super et al. 1997; Megonigal et al. 1998; Gillert
et al. 1999; Lovett et al. 2001; Rafﬁni et al. 2002) and
have been postulated to play a role in NHEJ (Roth et
al. 1985; Roth and Wilson 1986). A model of recom-
bination in which DNA double-stranded breaks (DSBs)
are inaccurately repaired by NHEJ has also been de-
scribed for deletions of PLP1 in patients with PMD
(Inoue et al. 2002).
Our data are consistent with a proposed model for
generation of tandem duplications that involves coupled
homologous and nonhomologous repair of a DSB
(Richardson and Jasin 2000; Helleday 2003). In this
model, events are initiated by a DSB with ends resected
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Figure 5 CLUSTALW alignment of 13 tandem duplication breakpoint sequences. Multiple sequence alignments between the 30-bp distal
and proximal breakpoint regions and the recombinant junction sequence generated using CLUSTALW are shown. Nucleotides present in all
three sequences are indicated by an asterisk (*). Overlap between distal and proximal sequences at the junction breakpoint (red letters) is
outlined by a box. Patient P015 had no overlap and a 2-bp insertion (underlined and in black letters). Distal and proximal sequences included
in the junction fragment are in green and blue letters, respectively, and those not included are in black letters. Two possibilities for the distal
clone of patient P083 are shown, with mismatches indicated in black letters. As indicated, there is no overlap at the junction if AL139229 is
at the junction. If AL139228 is at the junction, there is an overlap of 1 base, an A. Tracts of purines (R), pyrimidines (Y), or alternating purines
and pyrimidines (RY or YR) 110 bp in length are underlined. Those at the edge of the 30-bp sequence but present within the full-length sequence
are included. P348 has Y32 and Y11, P015 has YR14, P083 has RY12 and RY11, PMD9 has R11 and YR10, P255 has Y15 and Y12, P114
has Y12, and P176 has R10. Tandem repeats are indicated by arrows (P348).
by a 5′r3′ exonuclease, leaving single-stranded 3′ over-
hangs. At one side of the break, strand invasion of the
homologous region on the sister chromatid occurs, and
DNA synthesis is initiated at the 3′ invading end. This
conservative and usually error-free process would pro-
duce the proximal or distal breakpoint of the PMD
duplication in which there are no sequence errors. DNA
synthesis proceeds beyond the site of the DSB for the
length of the duplicated region, and the extended end
is then repaired by NHEJ with the free end of the DSB.
This error-prone mechanism would generate the ab-
normal junction that may have microhomology, inser-
tion, or deletion of several bases.
We examined the sequences at the breakpoints of our
13 tandem duplications for elements that might predis-
pose the region to DSB and rearrangement. We found
a high incidence of different interspersed repetitive el-
ements at the breakpoints, even though the actual per-
centage of interspersed repetitive DNA varied consid-
erably between the individual breakpoint regions. We
concluded that it is not simply a high density of inter-
spersed repetitive elements that is responsible for the
Xq22 instability and that other factors must be in-
volved. Similar ﬁndings of interspersed repetitive ele-
ments at breakpoints have been reported elsewhere, and
their presence has been postulated to be a frequent cause
of genomic rearrangement by NAHR, including both
deletions and duplications (Graw et al. 2000; Brooks
et al. 2001; Batzer and Deininger 2002; Lutskiy et al.
2002). Interestingly, the most comprehensive study of
genomewide human segmental duplications found an
enrichment of Alu repeats near or within breakpoints
(Bailey et al. 2003). In this study, junction analysis was
consistent with a model of homologous Alu-Alu non-
allelic recombination for the origin and dispersal of du-
plications both within and between chromosomes, al-
though far fewer tandem rearrangements were analyzed
compared with the more frequent interspersed dupli-
cations (Bailey et al. 2003). We do not have data sug-
gesting this mechanism for PLP1 duplications in PMD.
Our ﬁndings are consistent with a mechanism of NHEJ
and are more similar to the scattered deletion break-
points found within the dystrophin gene in patients with
Duchenne muscular dystrophy (Nobile et al. 2002;
Toffolatti et al. 2002). Interspersed repetitive elements
were reported at 42% (16 of 38) of the deletion break-
points (Nobile et al. 2002; Toffolatti et al. 2002), and
we found them at 69% (18 of 26) of our duplication
breakpoints. Furthermore, repetitive elements such as
Alu and MER5B have been associated with four cases
of nonrecurrent deletions on chromosome 17p11.2 that
were generated by NHEJ and NAHR (Shaw and Lup-
ski 2005). The signiﬁcance of repetitive elements located
at PLP1 duplication breakpoints remains unclear, but,
if we assume the model of coupled homologous and
nonhomologous recombination (Richardson and Jasin
2000), their presence does suggest that homologous in-
vasion could also occur within a downstream inter-
spersed repetitive element and that completion of the
event could occur by NHEJ or homologous annealing
(Richardson and Jasin 2000). Patient P110 had the larg-
est duplication (4.6 Mb) and an atypical pattern of
breakpoint sequences. Both were within an Alu repeat,
and a chimeric Alu element was formed at the break-
point junction. This may suggest the possible involve-
ment of either homology-assisted NHEJ or homologous
Alu-Alu recombination.
We found no evidence that secondary structures be-
tween DNA ends at the duplication junction were in-
volved in mediating the rearrangement or in promoting
the NHEJ event. Our analysis of 37 sequence motifs
previously associated with DNA rearrangements and
possibly involved in DNA cleavage and recombination
was unable to reveal a common mechanism for gener-
ation of the duplications. Our results supported the ap-
parent random distribution of breakpoints shown in the
mapping data in ﬁgure 1 and, taken together, may sug-
gest that the duplications are not mediated by speciﬁc
sequences. A lack of speciﬁc features at the DNA se-
quence level has also been reported in the rearrange-
ments, mainly deletions, in patients with Duchenne
muscular dystrophy (Sironi et al. 2003). However, we
did observe long stretches of purines and pyrimidines
or alternating purines and pyrimidines near many
breakpoints and spanning the breakpoint in two cases.
Tracts of purines and pyrimidines (110) can form Z-
DNA, which may be recombinogenic (Boehm et al.
1989; Majewski and Ott 2000). These tracts, particu-
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Figure 6 Complex rearrangements in three patients. For each patient, the extent of duplication predicted by multiplex PCR is indicated
by a line with circles at each end. The distance between the distal breakpoint predicted by multiplex PCR and the actual distal breakpoint
identiﬁed by sequence analysis of the junction fragment (A and B) or the distance between two potential distal breakpoints (C) is indicated by
a line with arrowheads at each end. The relative position of PLP1 is indicated by a black rectangle; potential breakpoint clones are indicated
by accession number; the relative positions of PCR primers used in the analysis are indicated by arrows; and the junctions predicted by multiplex
PCR and the actual sequenced junctions are diagrammed. A, Patient P134. B, Patient P255. The relative positions of the A1a and A1b repeats
of the LCR (diagrammed in detail in ﬁg. 7) are indicated by thick arrows. A unique region of clone Z70227 (254 bp) that is not present in
Z74620 is indicated by a striped rectangle. C, Patient P083. Relative positions of LINEs are indicated by striped arrows, and potential positions
of the distal breakpoint are indicated by an asterisk (*). The black arrowhead indicates a 55-bp region of clone AL139229. Not drawn to scale.
Figure 7 Analysis of repeats in the PLP1 genomic region. A, Region-speciﬁc repeats in the genomic region surrounding PLP1. A 2-Mb
human genomic sequence was masked for interspersed repetitive elements (UCSC Genome Browser, July 2003 release) and was compared
against itself by use of PipMaker (BLASTz). The alignments are shown as a dot plot and are plotted on the horizontal axis according to sequence.
Alignments—that is, repeated regions—are shown as black lines on the dot plot. Directly repeated sequences are represented as a series of dots
forming upward-facing diagonal lines (/), and inverted repeated sequences are represented as a series of dots forming downward-slopingdiagonal
lines (\). The checkerboard-like pattern proximal to PLP1 represents numerous short, locally repeated sequences. The densely packed lines distal
to PLP1 represent a large region of LCRs (further characterized in ﬁg. 7B). There was one small region of similarity to the LCR region found
proximal to PLP1 (104 bp with 73.08% identity) (oval). Other small regions of similarity on either side of PLP1 are shown by triangles,
squares, and circles (described further in table 4). The approximate locations of the chromosome bands in the region are shown underneath
the dot plot, and the position of PLP1 is indicated by a black box. B, Organization of LCRs distal to PLP1. The positions of the various repeat
elements are shown relative to genomic clones in the region. LCR-PMDC and LCR-PMDD are novel, and LCR-PMDA and LCR-PMDB
(including Ala, A2, A3, and Alb) have been described elsewhere (Inoue et al. 2002). In addition, two small inverted repeats were found in clone
Z70273 (277 and 332 bp in size), and another was found in AL390022 (356 bp). Arrows show the direction of each repeat, and the scale bar
shows their position on the X chromosome according to Ensembl.
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Table 4
Summary of the Short Regions of Sequence Similarity Identiﬁed
by BLASTz on Both Sides of PLP1
Clone
Symbol
in Figure 7a
Position
within Cloneb
Total Size
(bp)
Identityc
(%)
Z93848 Triangle 22975–26171 3,197 36.1
Z73964 Triangle 36996–39898 2,903 39.8
Z73965 Square 9469–9554 86 68.6
AL049631 Square 111144–111231 88 67.0
AL590407 Circle 26638–26549 90 65.6
AL121860 Circle 102438–102527 90 65.6
a Symbols corresponding to the ones used in ﬁgure 7 to highlight
these regions.
b The position (bp) of each repeat sequence within the sequence for
each genomic clone.
c The percentage of identical nucleotides within each alignment.
larly polypyrimidine, may also have a role in stimulating
DNA cleavage by including sites for topoisomerase II
(Spitzner et al. 1990) and by being associated with non-
homologous recombination events (Sperry et al. 1989).
Our study did not show the presence of topoisomerase
II sites near the breakpoints, at least within the 15 bp
examined on each side of the breakpoints. Recent anal-
ysis of chromosome breakpoints has shown that alter-
nating tracts of purines and pyrimidines and purine
tracts of 25–39 nt were signiﬁcantly overrepresented at
deletion breakpoints (Abeysinghe et al. 2003). Also,
polypurine tracts (2–23 bp) and polypyrimidine tracts
(2–44 bp) were signiﬁcantly overrepresented at trans-
location breakpoints (Abeysinghe et al. 2003). Our ﬁnd-
ing of purine and pyrimidine tracts at many but not all
breakpoints suggests that they may assist with but are
not necessary for stimulating the PLP1 duplications.
In several cases, a known gene or predicted gene was
found to span the duplication breakpoint, and thus the
patient would have normal and disrupted copies. In-
formation available about the disrupted genes at most
of the junctions was too preliminary to determine what
the signiﬁcance might be. At others, all that remains of
the gene is the 3′ end, and there is nothing predicted on
the other side to drive expression. However, in patient
P083, when the junction is in clone AL139228, there
is the potential for formation of a chimeric transcript
from the 5′ end of the RAB40A gene on the proximal
side and the 3′ end of a transcript of the RAB9 gene
(NCBI accession number BC018033) on the distal side
of the junction transcribed in telomere-to-centromere
orientation. We were unable to obtain tissue from the
patient to test for the presence of this transcript. The
protein products of these genes are members of the RAB
family of small G proteins that are key components in
intracellular vesicular transport and have been impli-
cated in oligodendrocyte membrane trafﬁcking (Rod-
riguez-Gabin et al. 2004). Although the coding region
of neither gene was included, the chimeric transcript
could potentially have clinical signiﬁcance if it were to
interfere with expression of either normal gene. The 5′
end of the interleukin 1 receptor accessory protein-like–
2 gene (IL1RAPL2), including two coding exons, was
present at the distal side of the junction for patient P176/
PMD7. However, it is unknown how far the transcript
would continue on the other side of the junction. No
transcripts of the same orientation were found nearby
on the other side of the junction. A transcript from this
partial gene could affect phenotype by interfering with
expression of IL1RAPL2 or by being translated into a
truncated protein with a dominant toxic effect. Alter-
natively, the transcript could be subject to nonsense-
mediated decay and not have a phenotypic effect. The
IL1RAPL2 gene is speciﬁcally expressed in the nervous
system and is affected in X-linked mental retardation
34 (Carrie et al. 1999; Ferrante et al. 2001). IL1RAPL2
has been shown to be a Toll receptor–like protein that
interacts with the neuronal calcium sensor–1 protein,
a modulator of neurotransmitter release (Bahi et al.
2003). However, the patient was not noted to have cog-
nitive defects unusual for PMD.
Although most of the junctions we identiﬁed were
indicative of simple tandem head-to-tail duplications,
at least 9 of the 59 patients in our cohort did not ﬁt
this picture. Of 36 patients tested by FISH, 3 had du-
plications inserted in a region outside Xq22: Xq26 in
PMD1 (Woodward et al. 2003), Xp22 in PMD5 (Hodes
et al. 2000), and the Y chromosome in P149/PMD46
(K.J.W. andM.C., unpublished data). Thus, an insertion
elsewhere is a relatively rare occurrence. Further, the
data suggest that six patients may have complex rear-
rangements. At least three of them—P015, P307, and
P389—had a second, nearby duplication in addition to
the PLP1-containing duplication when multiplex PCR
data were mapped with respect to the reference human
genome sequence (ﬁg. 1). These data could be explained
by internal deletions within duplicated regions, by re-
arrangements subsequent to the duplication event, or
by duplication events occurring on a substrate that is
rearranged with respect to the reference human genome
sequence. In patients P134 and P255, a discrepancy be-
tween the distal breakpoint predicted by dosage analysis
and the actual junction sequence identiﬁed (ﬁg. 6A and
6B), and the additional ﬁnding that P255 had a distal
breakpoint sequence in the inverse orientation from a
head-to-tail duplication, also suggested the possibility
of complex rearrangements. Patient P134 may have a
second junction in addition to the one we identiﬁed by
IPCR that involves the predicted distal clone. The sim-
plest explanation for the discrepancy in patient P255 is
that the duplication event occurred on a substrate that
had an inversion of the 99-kb region between the ex-
pected and the actual distal breakpoints with respect to
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the reference human genome sequence (see ﬁg. 6B). In
this regard, the expected and actual distal breakpoints
are in the A1b and A1a elements, respectively, of the
LCR distal to PLP1, which could mediate such an in-
version event. The duplication in patient P083, whose
distal breakpoint could be in LINEs in one of two
clones, could also have occurred on a substrate that
already had a rearrangement involving the LINEs. Al-
ternatively, 55 bp from clone AL139229 could have
been inverted and inserted at the junction with clone
AL139228, as diagrammed in ﬁgure 6C. The mecha-
nisms involved in generating these complex rearrange-
ments are largely unknown. The junction sequences sug-
gest that a nonhomologous repair mechanism was
involved in their formation, the same as for the tandem
head-to-tail duplications. We have no evidence for or
against complex rearrangement in any of the remaining
patients.
Although PMD differs mechanistically from many
other genomic diseases that are mediated by NAHR
between LCRs, the region of LCRs distal to the PLP1
gene may be involved in generating the duplications in
PMD. In this regard, it may be signiﬁcant that four of
the six patients with complex rearrangements and six
of the eight patients in whom we attempted to identify
junctions but failed to do so, possibly because they were
complex rearrangements, had their distal breakpoint in
or near the LCR region. In addition, the three small
PLP1 deletions reported elsewhere (Inoue et al. 2002)
had distal breakpoints within the region of LCRs, and
one of these cases had a complex rearrangement. Thus,
the region of LCRs would appear to be the area of
greatest instability close to the PLP1 gene. Although we
did not identify any further regions of LCRs, our anal-
ysis of the 2-Mb region susceptible to duplications iden-
tiﬁed many proximal-speciﬁc repeats that would not be
classiﬁed as LCRs because of their small size and low
homology. It is tempting to speculate that this unique
genomic architecture has a role in the nonrecurrent re-
arrangements that result in PMD by promoting insta-
bility in Xq22. More investigation is required to fully
understand the mechanisms involved in genomic rear-
rangements, particularly those of DNA duplication, but
this study shows that both homologous and nonhom-
ologous recombination mechanisms are involved. In ad-
dition, given that segmental duplications represent∼5%
of the human genome (Bailey et al. 2001), this analysis
of duplication events in patients with PMD provides a
valuable model for investigating the underlying molec-
ular mechanisms of other genomic duplications.
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